| PO1 | Advancing Automated Electrophysiology: Single-Channel Recordings in the Cell-Attached Configuration | Sophion A/S, Copenhagen, Denmark |
| PO3 | Identifying Brain-Permeable CRAC Channel Inhibitors Targeting CNS Disorders | University of Cambridge, Cambridge, UK |
| PO4 | Modulation of C6 Glioma Cell Motility by the Voltage-Gated Sodium Channel β3 Subunit | Dept. Biochemistry, University of Cambridge, UK |
| PO5 | High-throughput Automated Patch-Clamp Analysis Reveals Altered Excitability and Variation of Ion Channel activity in ALS iPSC-Derived Motor Neurons | Axol Bioscience, Cambridge, UK |
| PO6 | Co-application of Rapamycin and Analogues Enhances Agonist-induced TPC2 Activation | Department of Pharmacology, Cambridge, UK |
| PO7 | Improved Sensitivity for Detection of ECG Changes Due to hERG Channel Blockade Using Advanced Wave from Analysis of ECG Signals in Cardiac Drug Safety Studies Between Caucasian and Japanese Volunteer | Richmond Research Institute, London, UK King's College London, London, UK |
| PO8 | Advancing Structure‑Guided Drug Discovery for Lysosomal Ion Channels through the Integrated Protein Production, Biophysics, and Cryo‑EM Pipeline | Crelux, Gräfelfing, Germany |
| PO9 | Development of a High Throughput hNaV1.9 Automated Electrophysiology Assay | Metrion Biosciences, Cambridge, UK |
| PO10 | Molecular Arrangement and Modulation of Extrasynaptic αβδ GABAA Receptors | Department of Pharmacology, University of Cambridge, Cambridge, UK |
| PO11 | Validation of Antibody Fusions Against Sodium Channels | Metrion Biosciences, Cambridge, UK |
| PO12 | An Efficient and Scalable Human iPSC Trigeminal Neuron Platform for Pain Ion Channel Screening | Albion Drug Discovery Services Ltd, Cambridge, UK |
| PO13 | High-Throughput Electrophysiology Approaches for Early-Stage Drug Discovery Using Native Lysosomes | Nanion Technologies, Munich, Germany |
| PO14 | NMDA Receptor Subunit Composition Differentially Modulates GABAergic Inhibition of NMDA Spikes and Persistent Firing in Prefrontal Cortex Models | University of Southampton, Southampton, UK |
| PO15 | Inhibition of NMDA Receptors by Radiprodil in Neonatal Rat Substantia Nigra Dopaminergic Neurons | University College London, London, UK |
| PO16 | Controlling Excitability in Neuroendocrine Small Cell Lung Cancer | University of Cambridge, Cambridge, UK |
| PO17 | Effects of Age on Potassium Channel Modulation of Murine Gastrointestinal Motility | University of Hertfordshire, Hatfield, UK |
| PO18 | Machine Learning Design of Nanobodies Enables Affinity Maturation and α2/α3 Subtype Selectivity Switching in GABAA Receptors | University of Cambridge, Cambridge, UK |
| PO19 | High‑Throughput Characterisation of TMEM175 Conductance Properties and Pharmacological Modulators | Sygnature Discovery, Nottingham, UK |
| PO20 | Understanding Dravet Patient iPSC Derived Neuronal Function and Molecular Profile at the Single Cell Level | AstraZeneca, Cambridge, UK |
| PO21 | Characterising iPSC-derived Sensory Neurons for the Development of an In Vitro Arthritic-chronic Pain Model | AstraZeneca, Cambridge, UK |
| PO22 | Electrophysiological Characterisation of T-type (Cav3.x) Calcium Currents in SH-SY5Y Cells | University of Nottingham, UK |